4.7 Article

Genome-wide association analysis identifies new candidate risk loci for familial intracranial aneurysm in the French-Canadian population

Journal

SCIENTIFIC REPORTS
Volume 8, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-21603-7

Keywords

-

Funding

  1. Canadian Institutes of Health Research
  2. Canadian Heart and Stroke Foundation

Ask authors/readers for more resources

Intracranial Aneurysm (IA) is a common disease with a worldwide prevalence of 1-3%. In the French-Canadian (FC) population, where there is an important founder effect, the incidence of IA is higher and is frequently seen in families. In this study, we genotyped a cohort of 257 mostly familial FC IA patients and 1,992 FC controls using the Illumina NeuroX SNP-chip. The most strongly associated loci were tested in 34 Inuit IA families and in 32 FC IA patients and 106 FC controls that had been exome sequenced (WES). After imputation, one locus at 3p14.2 (FHIT, rs1554600, p = 4.66 x 10(-9)) reached a genome-wide significant level of association and a subsequent validation in Nunavik Inuit cohort further confirmed the significance of the FHIT variant association (rs780365, FBAT-O, p = 0.002839). Additionally, among the other promising loci (p < 5 x 10(-6)), the one at 3q13.2 (rs78125721, p = 4.77 x 10(-7)), which encompasses CCDC80, also showed an increased mutation burden in the WES data (CCDC80, SKAT-O, p = 0.0005). In this study, we identified two new potential IA loci in the FC population: FHIT, which is significantly associated with hypertensive IA, and CCDC80, which has potential genetic and functional relevance to IA pathogenesis, providing evidence on the additional risk loci for familial IA. We also replicated the previous IA GWAS risk locus 18q11.2, and suggested a potential locus at 8p23.1 that warrants further study.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Analysis of HeterozygousPRKNVariants and Copy-Number Variations in Parkinson's Disease

Eric Yu, Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Mehrdad A. Estiar, Dan Spiegelman, Matthew Surface, Stanley Fahn, Cheryl H. Waters, Lior Greenbaum, Alberto J. Espay, Yves Dauvilliers, Nicolas Dupre, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or

Summary: The study found no association between heterozygous single-nucleotide variants and CNVs in PRKN and the risk of PD. Pathogenic and likely-pathogenic variants were less common among PD patients than controls, with no associations found with age at onset.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder

Kheireddin Mufti, Uladzislau Rudakou, Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Isabelle Arnulf, Michele T. M. Hu, Jacques Y. Montplaisir, Jean-Francois Gagnon, Alex Desautels, Yves Dauvilliers, Gian Luigi Gigli, Mariarosaria Valente, Francesco Janes, Birgit Hoegl, Ambra Stefani, Evi Holzknecht, Karel Sonka, David Kemlink, Wolfgang Oertel, Annette Janzen, Giuseppe Plazzi, Elena Antelmi, Michela Figorilli, Monica Puligheddu, Brit Mollenhauer, Claudia Trenkwalder, Friederike Sixel-Doering, Valerie Cochen De Cock, Christelle Charley Monaca, Anna Heidbreder, Luigi Ferini-Strambi, Femke Dijkstra, Mineke Viaene, Beatriz Abril, Bradley F. Boeve, Ronald B. Postuma, Guy A. Rouleau, Ziv Gan-Or

Summary: The study found no significant role of autosomal dominant and recessive PD or atypical parkinsonism genes in the risk of iRBD. There was no association between rare heterozygous variants in the tested genes and the risk of iRBD. Homozygous and compound heterozygous carriers were not overrepresented in iRBD patients compared to controls.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations

Uladzislau Rudakou, Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Yves Dauvilliers, Dan Spiegelman, Lior Greenbaum, Stanley Fahn, Cheryl H. Waters, Nicolas Dupre, Guy A. Rouleau, Sharon Hassin-Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan-Or

Summary: This study conducted a comprehensive analysis of selected genes associated with Parkinson's disease, identifying significant rare and common genetic variants in genes like SYT11, FGF20, and GCH1. Additionally, potential novel associations were discovered in genes like PM20D1, BST1, and GPNMB. Fine mapping of GWAS loci revealed important insights into the genetics of Parkinson's disease.

BRAIN (2021)

Article Clinical Neurology

Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder

Kheireddin Mufti, Eric Yu, Uladzislau Rudakou, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Isabelle Arnulf, Michele T. M. Hu, Jacques Y. Montplaisir, Jean-Francois Gagnon, Alex Desautels, Yves Dauvilliers, Gian Luigi Gigli, Mariarosaria Valente, Francesco Janes, Andrea Bernardini, Birgit Hogl, Ambra Stefani, Evi Holzknecht, Karel Sonka, David Kemlink, Wolfgang Oertel, Annette Janzen, Giuseppe Plazzi, Elena Antelmi, Michela Figorilli, Monica Puligheddu, Brit Mollenhauer, Claudia Trenkwalder, Friederike Sixel-Doring, Valerie Cochen De Cock, Christelle Charley Monaca, Anna Heidbreder, Luigi Ferini-Strambi, Femke Dijkstra, Mineke Viaene, Beatriz Abril, Bradley F. Boeve, Jean-Francois Trempe, Guy A. Rouleau, Ronald B. Postuma, Ziv Gan-Or

Summary: Rare coding variants in BST1 and rare noncoding variants in LAMP3 are associated with iRBD. Further studies are needed to confirm these findings and explore the potential of targeting BST1 loss of function as a therapeutic approach.

NEUROLOGY (2021)

Article Clinical Neurology

Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7

Mehrdad A. Estiar, Eric Yu, Ikhlass Haj Salem, Jay P. Ross, Kheireddin Mufti, Fulya Akcimen, Etienne Leveille, Dan Spiegelman, Jennifer A. Ruskey, Farnaz Asayesh, Alain Dagher, Grace Yoon, Mark Tarnopolsky, Kym M. Boycott, Nicolas Dupre, Patrick A. Dion, Oksana Suchowersky, Jean-Francois Trempe, Guy A. Rouleau, Ziv Gan-Or

Summary: The study found a potential association between SPG7 variants and HSP, with a higher frequency of heterozygous SPG7 variants in HSP patients compared to controls. The results suggest complex inheritance patterns, including dominant and digenic/epistasis forms of inheritance.

MOVEMENT DISORDERS (2021)

Article Geriatrics & Gerontology

LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's disease

Yuri L. Sosero, Eric Yu, Lynne Krohn, Uladzislau Rudakou, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Stanley Fahn, Cheryl Waters, S. Pablo Sardi, Sara Bandres-Ciga, Roy N. Alcalay, Ziv Gan-Or, Konstantin Senkevich

Summary: The study found that the LRRK2 p.M1646T variant is associated with an increased risk of PD and elevated GCase activity in peripheral blood. However, the effect of this variant on PD risk is relatively small.

NEUROBIOLOGY OF AGING (2021)

Article Cell Biology

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

Paul J. Hop, Ramona A. J. Zwamborn, Eilis Hannon, Gemma L. Shireby, Marta F. Nabais, Emma M. Walker, Wouter van Rheenen, Joke J. F. A. van Vugt, Annelot M. Dekker, Henk-Jan Westeneng, Gijs H. P. Tazelaar, Kristel R. van Eijk, Matthieu Moisse, Denis Baird, Ahmad Al Khleifat, Alfredo Iacoangeli, Nicola Ticozzi, Antonia Ratti, Jonathan Cooper-Knock, Karen E. Morrison, Pamela J. Shaw, A. Nazli Basak, Adriano Chio, Andrea Calvo, Cristina Moglia, Antonio Canosa, Maura Brunetti, Maurizio Grassano, Marc Gotkine, Yossef Lerner, Michal Zabari, Patrick Vourc'h, Philippe Corcia, Philippe Couratier, Jesus S. Mora Pardina, Teresa Salas, Patrick Dion, Jay P. Ross, Robert D. Henderson, Susan Mathers, Pamela A. McCombe, Merrilee Needham, Garth Nicholson, Dominic B. Rowe, Roger Pamphlett, Karen A. Mather, Perminder S. Sachdev, Sarah Furlong, Fleur C. Garton, Anjali K. Henders, Tian Lin, Shyuan T. Ngo, Frederik J. Steyn, Leanne Wallace, Kelly L. Williams, Miguel Mitne Neto, Ruben J. Cauchi, Ian P. Blair, Matthew C. Kiernan, Vivian Drory, Monica Povedano, Mamede de Carvalho, Susana Pinto, Markus Weber, Guy A. Rouleau, Vincenzo Silani, John E. Landers, Christopher E. Shaw, Peter M. Andersen, Allan F. McRae, Michael A. van Es, R. Jeroen Pasterkamp, Naomi R. Wray, Russell L. McLaughlin, Orla Hardiman, Kevin P. Kenna, Ellen Tsai, Heiko Runz, Ammar Al-Chalabi, Leonard H. van den Berg, Philip Van Damme, Jonathan Mill, Jan H. Veldink

Summary: This study conducted a blood-based epigenome-wide association study meta-analysis and identified differentially methylated positions (DMPs) and genes associated with ALS. The study also found independent associations between ALS and high-density lipoprotein cholesterol, body mass index, white blood cell proportions, and alcohol intake, with cholesterol biosynthesis potentially causally related to ALS. Additionally, DNA methylation at several DMPs and blood cell proportion estimates were associated with survival rate in patients.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Clinical Neurology

Moyamoya Disease Susceptibility Gene RNF213 Regulates Endothelial Barrier Function

Vincent Roy, Jay P. Ross, Remy Pepin, Sergio Cortez Ghio, Alyssa Brodeur, Lydia Touzel Deschenes, Gaetan Le-Bel, Daniel E. Phillips, Genevieve Milot, Patrick A. Dion, Sylvain Guerin, Lucie Germain, Francois Berthod, Francois A. Auger, Guy A. Rouleau, Nicolas Dupre, Francois Gros-Louis

Summary: This study reveals that RNF213 may play a crucial role in maintaining cerebral endothelial cell integrity, and its disruption may contribute to the early pathological mechanism of Moyamoya disease. Additionally, the study further emphasizes the importance of blood-brain barrier integrity.

STROKE (2022)

Article Clinical Neurology

Association of Essential Tremor With Novel Risk Loci A Genome-Wide Association Study and Meta-analysis

Calwing Liao, Charles-Etienne Castonguay, Karl Heilbron, Veikko Vuokila, Miranda Medeiros, Gabrielle Houle, Fulya Akcimen, Jay P. Ross, Helene Catoire, Monica Diez-Fairen, Jooeun Kang, Stefanie H. Mueller, Simon L. Girard, Franziska Hopfner, Delia Lorenz, Lorraine N. Clark, Alexandra I. Soto-Beasley, Stephan Klebe, Mark Hallett, Zbigniew K. Wszolek, Manuela Pendziwiat, Oswaldo Lorenzo-Betancor, Klaus Seppi, Daniela Berg, Carles Vilarino-Guell, Ronald B. Postuma, Genevieve Bernard, Nicolas Dupre, Joseph Jankovic, Claudia M. Testa, Owen A. Ross, Thomas Arzberger, Sylvain Chouinard, Elan D. Louis, Paola Mandich, Carmine Vitale, Paolo Barone, Elena Garcia-Martin, Hortensia Alonso-Navarro, Jose A. G. Agundez, Felix Javier Jimenez-Jimenez, Pau Pastor, Alex Rajput, Gunther Deuschl, Gregor Kuhlenbaumer, Inge A. Meijer, Patrick A. Dion, Guy A. Rouleau

Summary: This genome-wide association study identified five independent loci associated with essential tremor (ET), explaining approximately 18% of its heritability. Functional analysis revealed enrichment in cerebellar regions. Genetic correlation analysis showed overlap with Parkinson disease and depression, suggesting common genetic factors.

JAMA NEUROLOGY (2022)

Article Biology

Transcriptome-wide association study reveals increased neuronal FLT3 expression is associated with Tourette's syndrome

Calwing Liao, Veikko Vuokila, Helene Catoire, Fulya Akcimen, Jay P. Ross, Cynthia V. Bourassa, Patrick A. Dion, Inge A. Meijer, Guy A. Rouleau

Summary: This study explores the biology of Tourette's Syndrome (TS) through transcriptome-wide association study and splicing analysis. It reveals increased expression of FLT3 gene in TS and its association with immune-related pathways.

COMMUNICATIONS BIOLOGY (2022)

Editorial Material Biochemistry & Molecular Biology

The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis

Kristiana Salmon, Jay P. Ross, Vanessa Bertone, Maria Gobbo, Nancy Anoja, Jason Karamchandani, Patrick A. Dion, Guy A. Rouleau, Angela Genge

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Genetics & Heredity

Transcriptomic effects of propranolol and primidone converge on molecular pathways relevant to essential tremor

Charles-Etienne Castonguay, Calwing Liao, Anouar Khayachi, Yumin Liu, Miranda Medeiros, Gabrielle Houle, Jay P. Ross, Patrick A. Dion, Guy A. Rouleau

Summary: This study used gene expression analysis to investigate the mechanisms of action of propranolol and primidone in treating essential tremor (ET). The results suggest that these drugs may reduce tremor symptoms by regulating specific genes and pathways, and identify relevant genetic biomarkers for drug responsiveness in ET.

NPJ GENOMIC MEDICINE (2022)

Article Genetics & Heredity

Questioning the Association of the STMN2 Dinucleotide Repeat With Amyotrophic Lateral Sclerosis

Jay P. Ross, Fulya Akcimen, Calwing Liao, Dan Spiegelman, Ben Weisburd, Nicolas Dupre, Patrick A. Dion, Guy A. Rouleau, Sali M. K. Farhan

Summary: Our study attempted to replicate the association between the CA repeat in the STMN2 gene and the risk for ALS. However, we did not find any evidence supporting this association in our case-control cohort and in genomes from different populations.

NEUROLOGY-GENETICS (2022)

Article Genetics & Heredity

Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids

Yoshitaka Tamaki, Jay P. Ross, Paria Alipour, Charles-etienne Castonguay, Boting Li, Helene Catoire, Daniel Rochefort, Makoto Urushitani, Ryosuke Takahashi, Joshua A. Sonnen, Stefano Stifani, Patrick A. Dion, Guy A. Rouleau

Summary: This study validated the propagation of TAR DNA-binding protein 43 kDa (TDP-43) pathology in human central nervous system (CNS) using induced pluripotent stem cells (iPSCs)-derived cerebral organoids. The results demonstrated that pathogenic TDP-43 from sporadic ALS patients could induce the formation of TDP-43 pathology in cerebral organoids and spread in a time-dependent manner. Additionally, the administration of ALS patient-derived protein extracts caused astrocyte proliferation, reproducing the pathological feature seen in ALS. These findings highlight the potential of using human cerebral organoids as a promising strategy for ALS research and drug discovery.

PLOS GENETICS (2023)

No Data Available